| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.66M | - | |
| CFO | 58.4K | $16.73M | - | |
| VP | 29.8K | $8.52M | - | |
| VP | 23.7K | $6.78M | - | |
| Dir | 23.2K | $6.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2018 | Schimmel Paul53 | Director | Sale+OE | 27,823 | $150.00 | $4,173,450.00 | -100% | |
| Mar 13, 2018 | Ausiello Dennis A | Director | Sale+OE | 17,117 | $150.00 | $2,567,550.00 | -100% | |
| Mar 13, 2018 | Keating Laurie55 | SVP, GC &Secretary | Sale+OE | 20,000 | $145.00 | $2,900,000.00 | -40.8% | |
| Mar 9, 2018 | Sharp Philip A45 | Director | Sale+OE | 15,000 | $129.00 | $1,935,000.00 | -9.6% | |
| Jan 4, 2018 | Mason Michael88 | VP, Finance And Treasurer | Sale+OE | 36,745 | $131.59 | $4,835,170.66 | -42.0% | |
| Dec 20, 2017 | Keating Laurie55 | SVP, GC &Secretary | Sale+OE | 6,249 | $121.20 | $757,398.40 | -14.4% | |
| Dec 1, 2017 | Keating Laurie55 | SVP, GC And Secretary | Sale+OE | 30,000 | $135.89 | $4,076,823.30 | -18.7% | |
| Nov 22, 2017 | Maraganore John | Chief Executive Officer | Sale+OE | 73,415 | $130.90 | $9,609,736.44 | -9.8% | |
| Nov 15, 2017 | Maraganore John | Chief Executive Officer | Sale+OE | 74,000 | $126.86 | $9,387,951.30 | -6.9% | |
| Nov 2, 2017 | Ausiello Dennis A | Director | Sale+OE | 20,000 | $130.00 | $2,600,000.00 | -100% |